Changes in the Management of Bioiberica
Statement:
At the end of May 2016, Mr. Josep Escaich has ceased to be the CEO of Bioibérica S.A. The Board of Directors of Bioibérica nominated Mr. Jordi Vidal as interim Chief Operating Officer (COO) joining the Management of Bioibérica for the coming months to support the transition until a new CEO will be nominated. Mr. Vidal is an experienced executive who has worked in Rhenus South-Europe for 5 years and before in Cognis Iberia for 8 years.
The Board is very confident that the Management of Bioibérica will be able to realise with the experienced, dedicated and highly motivated team of Bioibérica, a successful transition developing forward Bioiberica's important customer relationships and its good market position.
Related News
We participated in CPHI 2023 in Barcelona, where we showcased our leadership in scientific research, sustainable development and strategic partnerships for a more resilient future with our portfolio of Active Pharmaceutical and Nutraceutical Ingredients.
They've set up Biovall Heparin Science, a joint pharmaceutical innovation project with an investment of 25 million euros and 20 skilled jobs
Join Bioiberica at stand F130 in Geneva, 9-11 May to discover the company’s latest science and insights driving innovation in the nutraceuticals market.